doi: 10.1007/s00705-008-0110-1.
Epub 2008 Jun 13.
Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA
Affiliations
- PMID: 18551244
- DOI: 10.1007/s00705-008-0110-1
Item in Clipboard
Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA
Arch Virol.
2008.
Abstract
RNA interference (RNAi) is a process by which introduced small interfering RNA (siRNA) can cause the specific degradation of mRNA with identical sequences. In this study, we applied siRNAs targeting the UL39 gene of human herpes simplex virus type 1 (HSV-1), which encodes the large subunit of ribonucleotide reductase, ICP6. Using an ICP6 expression reporter plasmid and an in vitro model of infection, we showed that synthetic siRNA silenced effectively and specifically UL39 mRNA expression and inhibited HSV-1 replication. Our work offers new possibilities for RNAi as a genetic tool for inhibition of HSV-1 replication.
Similar articles
-
Effect of siRNAs on HSV-1 plaque formation and relative expression levels of RR mRNA.Virol Sin. 2011 Feb;26(1):40-6. doi: 10.1007/s12250-011-3162-9. Epub 2011 Feb 18. Virol Sin. 2011. PMID: 21331889 Free PMC article.
-
Herpes Simplex Virus 1 Mutant with Point Mutations in UL39 Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation.J Virol. 2018 Mar 14;92(7):e01654-17. doi: 10.1128/JVI.01654-17. Print 2018 Apr 1. J Virol. 2018. PMID: 29321311 Free PMC article.
-
Short hairpin RNA-mediated inhibition of HSV-1 gene expression and function during HSV-1 infection in Vero cells.Acta Pharmacol Sin. 2008 Aug;29(8):975-82. doi: 10.1111/j.1745-7254.2008.00828.x. Acta Pharmacol Sin. 2008. PMID: 18664330
-
Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.Int J Mol Med. 2007 Apr;19(4):705-11. Int J Mol Med. 2007. PMID: 17334648
-
Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.Adv Drug Deliv Rev. 2009 Jul 25;61(9):760-6. doi: 10.1016/j.addr.2009.04.006. Epub 2009 Apr 20. Adv Drug Deliv Rev. 2009. PMID: 19386274 Review.
Cited by
-
Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen.PLoS One. 2013;8(1):e53276. doi: 10.1371/journal.pone.0053276. Epub 2013 Jan 3. PLoS One. 2013. PMID: 23301054 Free PMC article.
-
Small interfering RNA targeting for infected-cell polypeptide 4 inhibits herpes simplex virus type 1 replication in retinal pigment epithelial cells.Clin Exp Ophthalmol. 2012 Mar;40(2):195-204. doi: 10.1111/j.1442-9071.2011.02668.x. Epub 2011 Oct 20. Clin Exp Ophthalmol. 2012. PMID: 21883773 Free PMC article.
-
Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.J Neurovirol. 2016 Dec;22(6):799-807. doi: 10.1007/s13365-016-0453-4. Epub 2016 Aug 26. J Neurovirol. 2016. PMID: 27566181
-
Effect of siRNAs on HSV-1 plaque formation and relative expression levels of RR mRNA.Virol Sin. 2011 Feb;26(1):40-6. doi: 10.1007/s12250-011-3162-9. Epub 2011 Feb 18. Virol Sin. 2011. PMID: 21331889 Free PMC article.
-
High silent prevalence of human herpesvirus 1 (HSV-1) infection affecting the indigenous reservation of the municipality of Dourados, Central-West Brazil.BMC Infect Dis. 2024 Jul 17;24(1):700. doi: 10.1186/s12879-024-09497-5. BMC Infect Dis. 2024. PMID: 39020287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
